Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

F.E. van Leeuwen; A.M.J. Chorus; A.W. van den Belt-Dusebout; A. Hagenbeek; R. van Noyon; E.H.M. Kerkhoff; H.M. Pinedo; R. Somers

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

F.E. van Leeuwen, A.M.J. Chorus, A.W. van den Belt-Dusebout, A. Hagenbeek, R. van Noyon, E.H.M. Kerkhoff, H.M. Pinedo, R. Somers

VU University medical center

Research output: Contribution to journal › Article › Academic › peer-review

118 Downloads (Pure)

Original language	English
Pages (from-to)	1063-1073
Journal	Journal of Clinical Oncology
Volume	12
Issue number	5
Publication status	Published - 1994

Access to Document

8658Final published version, 10 MB

Cite this

van Leeuwen, F. E., Chorus, A. M. J., van den Belt-Dusebout, A. W., Hagenbeek, A., van Noyon, R., Kerkhoff, E. H. M., Pinedo, H. M., & Somers, R. (1994). Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. Journal of Clinical Oncology, 12(5), 1063-1073.

@article{25d39a627779404a92678faedfe0ba40,

title = "Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage",

author = "{van Leeuwen}, F.E. and A.M.J. Chorus and {van den Belt-Dusebout}, A.W. and A. Hagenbeek and {van Noyon}, R. and E.H.M. Kerkhoff and H.M. Pinedo and R. Somers",

year = "1994",

language = "English",

volume = "12",

pages = "1063--1073",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "5",

}

van Leeuwen, FE, Chorus, AMJ, van den Belt-Dusebout, AW, Hagenbeek, A, van Noyon, R, Kerkhoff, EHM, Pinedo, HM & Somers, R 1994, 'Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage', Journal of Clinical Oncology, vol. 12, no. 5, pp. 1063-1073.

Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. / van Leeuwen, F.E.; Chorus, A.M.J.; van den Belt-Dusebout, A.W. et al.

In: Journal of Clinical Oncology, Vol. 12, No. 5, 1994, p. 1063-1073.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage

AU - van Leeuwen, F.E.

AU - Chorus, A.M.J.

AU - van den Belt-Dusebout, A.W.

AU - Hagenbeek, A.

AU - van Noyon, R.

AU - Kerkhoff, E.H.M.

AU - Pinedo, H.M.

AU - Somers, R.

PY - 1994

Y1 - 1994

M3 - Article

SN - 0732-183X

VL - 12

SP - 1063

EP - 1073

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 5

ER -